93/12 (Pantoprazole sodium delayed-release 40 mg)
Pill imprint 93/12 has been identified as Pantoprazole sodium delayed-release 40 mg.
Pantoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; zollinger-ellison syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 93/12
- 40 mg
- 10.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium carbonate
D&C Yellow No. 10
FD&C Yellow No. 6
hypromellose 2910 (15 mPa.s)
ferric oxide yellow
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 4000
|NDC Code||Manufacturer / Repackager|
|18837-0296||Innoviant Pharmacy Inc (repackager)|
|54868-5846||Physicians Total Care Inc (repackager)|
|68071-0782||Nucare Pharmaceuticals Inc (repackager)|
|66336-0405||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.